Strength
5 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722072830
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
MONTELUKASTApproval Type
Generic (ANDA)
FDA Application
ANDA204093On Market Since
5/27/2015
Pharmacological Classes
Leukotriene Receptor Antagonist
Leukotriene Receptor Antagonists
Related Drugs
Same classification
MONTELUKAST SOD 10 MG TABLET
Generic
00904680806•Major Pharmaceuticals
$0.0435
per EA
MONTELUKAST SOD 10 MG TABLET
Generic
00904680861•Major Pharmaceuticals
$0.0435
per EA
MONTELUKAST SOD 10 MG TABLET
Generic
13668008105•Torrent Pharmaceuticals Limited
$0.0435
per EA
MONTELUKAST SOD 10 MG TABLET
Generic
13668008130•Torrent Pharmaceuticals Limited
$0.0435
per EA
MONTELUKAST SOD 10 MG TABLET
Generic
13668008190•Torrent Pharmaceuticals Limited
$0.0435
per EA
MONTELUKAST SOD 10 MG TABLET
Generic
16571010009•Rising Pharma Holdings Inc.
$0.0435
per EA
MONTELUKAST SOD 10 MG TABLET
Generic
16571010010•Rising Pharma Holdings Inc.
$0.0435
per EA
MONTELUKAST SOD 10 MG TABLET
Generic
16729011910•Accord Healthcare Inc.
$0.0435
per EA
MONTELUKAST SOD 10 MG TABLET
Generic
16729011917•Accord Healthcare Inc.
$0.0435
per EA
MONTELUKAST SOD 10 MG TABLET
Generic
31722072610•Camber Pharmaceuticals Inc.
$0.0435
per EA